Better Therapeutics Inc. (BTTX)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 31, 2025, 3:22 PM

Dividends

No dividend history available for Better Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

BTTX News

10 months ago · Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc. - businesswire.com
1 year ago · Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq - businesswire.com
1 year ago · Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers - businesswire.com
1 year ago · Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) - businesswire.com
1 year ago · Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status - zacks.com
1 year ago · Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease - businesswire.com
1 year ago · Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment - businesswire.com
1 year ago · Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone - businesswire.com
1 year ago · Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States - businesswire.com
1 year ago · Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease - businesswire.com